menu toggle

Manufacturer Solutions

Health Economics & Market Access Solutions

Our leading team of value experts transforms evidence, policy insights, and market intelligence into effective global market access strategies helping clients effectively navigate today’s complex healthcare landscape.
Xcenda_1upCard_03

Global reach. Local expertise.

With offices across North America and Europe our consultants and strategic advisors bring local insights and expertise to ensure the greatest opportunity for success of your product, regardless of the geographic market you’re looking to enter.
500+
Associates worldwide
30+
Global markets covered
235+
Brands represented

End-to-end consulting services

Optimize market access, awareness, and outcomes through expert guidance with a proven track record of success.

Global health economics and outcomes research (HEOR)

We combine rigorous, technical expertise with an understanding of local markets and multiple disease states to deliver relevant, transparent, and credible results to help inform practical strategies and tactics that communicate a robust portfolio of value-based evidence.

Market access consulting and communications

From market-shaping and disease awareness efforts to conducting full POA meeting and training engagements, our unique collaboration between science, design, and client services generates innovative work that resonates with formulary decision makers.

Regulatory consulting

With years of experience and expertise in regulatory strategy, dossier authoring, submission preparation and lifecycle management we navigate your product through the complete regulatory approval process with Health Canada or US Food and Drug Administration (FDA).

Real world evidence

With access to more than 100 data sources and over 100,000 healthcare providers, our team knows the right questions to ask to develop an evidence portfolio that achieves your brand goals.

Reimbursement & policy insights

Using detailed data analyses, including market assessment, payment system modeling, budget scoring, and payer and formulary analyses, our team delivers evidence-based insights and recommendations that help increase patient access. 

Pharmacovigilance

Our comprehensive Pharmacovigilance and Medical Information services help ensure compliance with continually evolving regulatory requirements ensuring the highest quality of safety data collection and processing.
Global market access consulting

Global market access consulting

Transforming evidence and market intelligence into effective global strategies and solutions. From market access consulting to health economics & outcomes research to real-world evidence, our global solutions team helps unlock product potential worldwide. 
Xcenda_1Card_01

Market research and advisor networks

Xcenda_1Card_01
Conduct research with our prestigious advisor networks and tap into insights from healthcare's most respected authorities and decision makers. Whether you need to gather payer insights, capture provider and practice behaviors, or acquire specific knowledge of submission processes around the world, engage with our industry experts for critical guidance that drives product success.
Xcenda_1Card_01
Innomar_2_3 Card-01

Our businesses

Innomar Strategies

Innomar_2_3 Card-01
Innomar Strategies is the leading patient support provider in the Canadian specialty pharmaceutical market. We help manufacturers navigate the complex healthcare environment and gain market access with turnkey, end-to-end commercialization solutions and consultative services.
Innomar_2_3 Card-01
Product injectable

Our businesses

TPI Reg

Product injectable
TPIreg™ provides Regulatory Affairs services for prescription and non-prescription pharmaceuticals and biologics, medical devices, combination products, natural health products, and cosmetics. The Regulatory Team includes members skilled in clinical/non-clinical, chemistry manufacturing and control (CMC), risk management, and labelling.
Product injectable
FormularyDecisions-body1-504x504x2

Maximize brand visibility

Exchange information with thousands of payers

FormularyDecisions is a secure, online platform facilitating the bi-directional exchange of information between life sciences companies and over 2,400 qualified, active healthcare decision-makers. From pre-approval to post-launch, get unrivaled insight into what payers think of your product and those of your competitors, and gain feedback to better inform your market access strategies.

Featured Insights

meeting

Insight

Leverage enterprise thinking for commercialization progress


AmerisourceBergen
April 2024

Cell and gene therapy consultants

Insight

Opportunities and pain points for CGT innovation and market access

Lung-I Cheng
AmerisourceBergen
February 2024

Insight

Planning for the World: Q&A With Sandra Anderson, SVP of International Commercialization at Cencora


AmerisourceBergen
February 2024

Xcenda_2_3_Card-02

Keep up on key global health technology assessment news

HTA Quarterly

Each edition of HTA Quarterly provides insights and analysis from global experts with local market expertise on key priorities and perspectives affecting HTA.  

From therapeutic area spotlights to geographic reviews to critical industry topics, keep current on HTA activity around the globe with HTA Quarterly.

US Capitol building

Health Policy Weekly

US Capitol building
Health Policy weekly recaps legislative and regulatory developments and healthcare reform news that impacts the healthcare industry, particularly pharmaceutical, biotech, and device manufacturers, providers, and managed care.

Developed by a multi-disciplinary editorial board that includes health policy and reimbursement strategy experts, Health Policy Weekly delivers key insights to your inbox every week. 
US Capitol building

We are Cencora. Our shared identity unites us.

Cencora brings the companies and services of AmerisourceBergen together under one new name. Check out our full life cycle commercialization solutions, and contact us today to learn more.